T834-0526 Screening compound: 5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

T834-0526 Screening compound: 5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide
T834-0526 Screening compound: 5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T834-0526
5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T834-0526

Molecular Formula

C21H17F3N4O3 (C21 H17 F3 N4 O3)

Compound Name

5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

IUPAC name

5-ethyl-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-2-carboxamide

SMILES

CCN(c(cccc1)c1-n(c1c2)nc2C(Nc(cc2)cc(C(F)(F)F)c2OC)=O)C1=O

InChI

InChI=1S/C21H17F3N4O3/c1-3-27-15-6-4-5-7-16(15)28-17(20(27)30)11-14(26-28)19(29)25-12-8-9-18(31-2)13(10-12)21(22,23)24/h4-11H,3H2,1-2H3,(H,25,29)

InChI Key

MQCPVIUFSUFCCN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29029406

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.823

Distribution Coefficient, logD

3.798

Water Solubility, LogSw

-4.06

Polar Surface Area

58.423

Acid Dissociation Constant (pKa)

8.63

Base Dissociation Constant (pKb)

-4.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

T834-0526 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral HBV Library (10007 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with T834-0526 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T834-0526?
Check Price and Availability of T834-0526, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T834-0526 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T834-0526
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T834-0526
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T834-0526 available by request